Eloxx Pharmaceuticals, Inc. (ELOX)
19.99
-0.98
(-4.70%)
USD |
OTCM |
Aug 24, 16:00
Eloxx Pharmaceuticals Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| June 30, 2025 | |
| September 30, 2023 | -0.2872 |
| June 30, 2023 | -0.3284 |
| March 31, 2023 | -0.3827 |
| December 31, 2022 | -1.256 |
| September 30, 2022 | -2.692 |
| June 30, 2022 | 7.415 |
| March 31, 2022 | 1.147 |
| December 31, 2021 | 0.6012 |
| September 30, 2021 | 0.4104 |
| June 30, 2021 | 0.2755 |
| March 31, 2021 | 3.914 |
| December 31, 2020 | 1.177 |
| September 30, 2020 | 0.8815 |
| June 30, 2020 | 0.7162 |
| March 31, 2020 | 0.5705 |
| December 31, 2019 | 0.4353 |
| September 30, 2019 | 0.3438 |
| June 30, 2019 | 0.2811 |
| March 31, 2019 | 0.4501 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.00 |
| June 30, 2017 | 0.4673 |
| March 31, 2017 | 0.0994 |
| December 31, 2016 | 0.1055 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.2833 |
| September 30, 2013 | 1.033 |
| June 30, 2013 | 0.5777 |
| March 31, 2013 | 0.6605 |
| December 31, 2012 | 1.391 |
| September 30, 2012 | 0.8364 |
| June 30, 2012 | 0.6369 |
| March 31, 2012 | 0.4782 |
| December 31, 2011 | 0.7762 |
| September 30, 2011 | 0.5591 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Filana Therapeutics, Inc. | 0.00 |
| CorMedix, Inc. | 0.315 |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.2335 |
| BioStem Technologies, Inc. | 0.0443 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 63.39M |
| Total Liabilities (Quarterly) | 16.97M |
| Shareholders Equity (Quarterly) | 46.42M |
| Current Ratio | 3.736 |
| Net Debt Paydown Yield | 2.23% |